Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Antiviral Res. 2014 Jun 2;108:74–78. doi: 10.1016/j.antiviral.2014.05.014

Figure 2.

Figure 2

Pharmacokinetics of SAHA in 4 FIV+ cats (165, 184, 186, and 187) and 1 FIV- control cat (185) administered 250 mg/m2 oral SAHA with food. The average (dotted black line) represents data excluding cat #165 (see text). Serum samples were analyzed by UPLC coupled to tandem mass spectrometry using deuterated SAHA as an internal standard.